Is Peptide Library Canada: Research Reference Guide intended for research and educational context?

Yes. This guide is written for research and educational context. It is intended for research and educational purposes only, not for diagnosis, treatment, dosing, or human-use instructions.

How should readers use this Luvi guide?

Use it as a starting point to understand terminology, compare key concepts, and decide what additional source material or product information to review before making decisions.

Peptide Library Canada: Research Reference Guide

Q: What is Peptide Library Canada: Research Reference Guide about?

Explore LuviScience peptide dose and schedule references for Canadian researchers, with peptide categories, calculator links, and product research pages.

Peptide Library for Canadian Researchers

Use this peptide library as a research-focused reference for peptide categories, concentration references, research summaries, and product pages available through LuviScience.

Open the peptide calculator or browse LuviScience products.

✅ Community Trusted

Peptide Research Reference

Comprehensive data sourced from published research. Built for Canadian researchers.

Loading peptides…

Name (A–Z)

Can’t find what you’re looking for?

Request a peptide →

[{“abbr”: “ACE-031”, “name”: “ACE-031”, “sub”: “Activin Receptor Type IIB Inhibitor”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–300 mcg”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Muscle”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “ACE-083”, “name”: “ACE-083”, “sub”: “Locally-Acting Follistatin Fusion Protein”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “50000–200000 mcg”, “route”: “IM”, “cycle”: “12-24 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Muscle”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “ADA”, “name”: “Adamax”, “sub”: “Next-Generation Semax Derivative | Nootropic Neuropeptide”, “desc”: “Adamax is a synthetic nootropic peptide and enhanced derivative of Semax, featuring N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration. It’s researched for cognitive enhancement, neuroprotection, neuroplasticity, and potential therapeutic applications in stroke recovery and mood disorders.”, “uses”: [“Cognitive Enhancement”, “Neuroplasticity Support”, “Learning and Memory”, “Stroke Recovery”, “Oxidative Stress Protection”], “research amount”: “200-300mcg”, “route”: “Injectable”, “cycle”: “2-4 weeks”, “storage”: “2-8°C”, “level”: “limited”, “category”: “Cognitive Enhancement, Neurological Support, Mood Support”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Adipotide”, “name”: “Adipotide (Prohibitin‑TP01)”, “sub”: “Prohibitin‑Targeting Peptidomimetic | Experimental Anti‑Obesity”, “desc”: “Adipotide (Prohibitin‑TP01) is a chimeric, adipose‑vasculature–targeted peptidomimetic that homes to prohibitin/annexin A2 on white adipose tissue endothelium and delivers a pro‑apoptotic D‑(KLAKLAK)2 motif. In obese primates it produced rapid fat loss with improved insulin resistance, but development halted after an early Phase 1 oncology trial; kidney safety signals (reversible proximal tubule changes) remain a key concern.”, “uses”: [“White Adipose Reduction”, “Insulin Sensitivity”, “Peripheral Approach”], “research amount”: “0.43 mg/kg”, “route”: “Injectable”, “cycle”: “28 days”, “storage”: “2–8°C (reconstituted)”, “level”: “emerging”, “category”: “Hormone Balance, Metabolism Support, Appetite Control”, “source”: “both”, “url”: “”}, {“abbr”: “Alpha-MSH”, “name”: “Alpha-MSH”, “sub”: “Alpha-Melanocyte Stimulating Hormone”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “250–1000 mcg”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Tanning”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Ang-(1-7)”, “name”: “Ang-(1-7)”, “sub”: “Angiotensin 1-7 Peptide”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–1000 mcg”, “route”: “SubQ”, “cycle”: “4-12 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Cardiovascular”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “AOD-9604”, “name”: “AOD-9604”, “sub”: “Advanced Obesity Drug | Modified hGH Fragment 176-191”, “desc”: “AOD-9604 is a modified 17-amino acid fragment of human growth hormone (hGH 176-191) with an added N-terminal tyrosine. It stimulates lipolysis and inhibits lipogenesis without the growth-promoting effects of full hGH. Unlike intact growth hormone, AOD-9604 does not increase IGF-1, affect glucose metabolism, or bind to the GH receptor.”, “uses”: [“Fat Loss”, “Fat Loss / Lipolysis”, “Lipogenesis Inhibition”, “Metabolic Safety”, “Joint”], “research amount”: “250-500mcg”, “route”: “Injectable”, “cycle”: “8-12 weeks”, “storage”: “2-8°C”, “level”: “extensive”, “category”: “Fat Loss”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/aod9604-5mg/”}, {“abbr”: “A2R”, “name”: “Ara 290”, “sub”: “Tissue-Protective Peptide | Innate Repair Receptor Agonist”, “desc”: “Ara 290 (Cibinetide) is an engineered 11-amino acid peptide derived from erythropoietin that activates the Innate Repair Receptor (IRR) to provide tissue-protective effects without stimulating red blood cell production. It has completed multiple Phase 2 clinical trials and holds FDA Orphan Drug status for several indications.”, “uses”: [“Peripheral Nerve Regeneration”, “Diabetic Neuropathy Treatment”, “Central Nervous System Protection”, “Cytokine Reduction”, “Inflammatory Bowel Disease”], “research amount”: “1-8 mg”, “route”: “Injectable”, “cycle”: “28 days”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Neurological Support, Anti-Inflammatory, Tissue Repair”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “ARA-290”, “name”: “ARA-290”, “sub”: “Tissue-Protective Peptide | Innate Repair Receptor Agonist”, “desc”: “Ara 290 (Cibinetide) is an engineered 11-amino acid peptide derived from erythropoietin that activates the Innate Repair Receptor (IRR) to provide tissue-protective effects without stimulating red blood cell production. It has completed multiple Phase 2 clinical trials and holds FDA Orphan Drug status for several indications.”, “uses”: [“Neuroprotection”, “Peripheral Nerve Regeneration”, “Diabetic Neuropathy Treatment”, “Central Nervous System Protection”, “Anti Inflammatory”, “Tissue Repair”, “Autoimmune”], “research amount”: “1-8 mg”, “route”: “Injectable”, “cycle”: “28 days”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Inflammation”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “BPC-157”, “name”: “BPC-157”, “sub”: “Body Protection Compound-157 | Pentadecapeptide”, “desc”: “BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. It’s known for its remarkable healing properties and is extensively researched for tissue repair, inflammation reduction, and gastrointestinal protection. Not FDA approved and prohibited by WADA (added 2022) under S0: Non-Approved Substances – no TUE available for athletes.”, “uses”: [“Wound Healing”, “Tendon Healing”, “Muscle Recovery”, “Angiogenesis”, “Neurological”, “Gastrointestinal”], “research amount”: “250-500mcg”, “route”: “Injectable”, “cycle”: “4-8 weeks”, “storage”: “2-6°C”, “level”: “extensive”, “category”: “Healing”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/bpc-157/”}, {“abbr”: “BPC-157 Arginate”, “name”: “BPC-157 Arginate”, “sub”: “BPC-157 Arginate (Injectable Form)”, “desc”: “”, “research amount”: “250-500 mcg daily”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “Room temperature or refrigerated”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “CAG”, “name”: “Cagrilintide”, “sub”: “Long-Acting Amylin Receptor Agonist | Hormone Balance & Diabetes”, “desc”: “Cagrilintide (AM833) is a novel long-acting lipidated amylin analog that acts as a dual amylin and calcitonin receptor agonist. Developed for weight management and type 2 diabetes treatment, it shows superior hormone balance potential when combined with GLP research compounds (CagriSema), with recent Phase 3 trials demonstrating up to 22.7% weight reduction.”, “uses”: [“Superior Obesity Treatment”, “Type 2 Diabetes Weight Management”, “Sustained Weight Maintenance”, “Glucose Control Enhancement”, “Insulin Sensitivity Improvement”], “research amount”: “2.4 mg weekly”, “route”: “Injectable”, “cycle”: “Continuous”, “storage”: “-20°C”, “level”: “well”, “category”: “Hormone Balance, Metabolism Support, Appetite Control”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “CER”, “name”: “Cerebrolysin”, “sub”: “Neuropeptide Preparation | Neurological Recovery”, “desc”: “Cerebrolysin is a standardized neuropeptide preparation derived from purified porcine brain proteins, containing bioactive peptides and amino acids that exhibit neurotrophic and neuroprotective properties for stroke recovery, traumatic brain injury, and cognitive enhancement.”, “uses”: [“Alzheimer’s Disease – Mixed Evidence”, “Vascular Dementia – Established Efficacy”, “Post-Stroke Cognitive Recovery”, “Acute Stroke – Evidence Mixed”, “Traumatic Brain Injury – Strong Evidence”], “research amount”: “10-50 mL”, “route”: “Injectable”, “cycle”: “7-30 days”, “storage”: “Room temp ≤25°C”, “level”: “well”, “category”: “Cognitive Enhancement, Neurological Support, Recovery”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Cetrorelix”, “name”: “Cetrorelix”, “sub”: “Cetrorelix (GnRH Antagonist)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “250–3000 mcg”, “route”: “SubQ”, “cycle”: “As directed”, “storage”: “”, “level”: “emerging”, “category”: “Hormonal”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “CGRP”, “name”: “CGRP”, “sub”: “Calcitonin Gene-Related Peptide”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “50–300 mcg”, “route”: “SubQ”, “cycle”: “As needed”, “storage”: “”, “level”: “emerging”, “category”: “Pain”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “CJC-1295 (no DAC)”, “name”: “CJC-1295 (no DAC)”, “sub”: “Short-Acting Growth Hormone Releasing Hormone Analog | Modified GRF 1-29”, “desc”: “CJC-1295 without DAC is a Growth Hormone Releasing Hormone (GHRH) analog with a short half-life of approximately 30 minutes. It stimulates the pituitary gland to release growth hormone, making it popular for research into muscle growth, fat loss, and recovery. The shorter half-life requires more frequent research protocol compared to the DAC version.”, “uses”: [“Growth Hormone Increase”, “Muscle Growth”, “Fat Loss”, “Recovery Enhancement”], “research amount”: “100-300mcg per injection”, “route”: “Injectable”, “cycle”: “12-16 weeks”, “storage”: “2-8°C”, “level”: “well”, “category”: “Growth Hormone”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/cjc-1295-no-dac/”}, {“abbr”: “CJC-1295 (DAC)”, “name”: “CJC-1295 with DAC”, “sub”: “Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release”, “desc”: “CJC-1295 with DAC features a Drug Affinity Complex that extends its half-life to approximately 8 days, allowing for less frequent research protocol. As a GHRH analog, it stimulates growth hormone secretion from the pituitary gland. Popular in research for muscle growth, fat metabolism, anti-aging, and recovery enhancement. The DAC technology binds to serum albumin, providing sustained release.”, “uses”: [“Growth Hormone Increase”, “Muscle Growth”, “Fat Loss”, “Anti-Aging”, “Recovery Enhancement”], “research amount”: “1-2mg per week”, “route”: “Injectable”, “cycle”: “8-12 weeks”, “storage”: “2-8°C”, “level”: “well”, “category”: “Growth Hormone”, “url”: “https://luviscience.com/product/cjc-1295-with-dac/”, “source”: “luvi”}, {“abbr”: “Colivelin”, “name”: “Colivelin”, “sub”: “Colivelin (Humanin-STAT3 Fusion Peptide)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “10–50 mcg”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Vitality After 40”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Cortagen”, “name”: “Cortagen”, “sub”: “Cortagen (AEDG Neural Bioregulator)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–500 mcg”, “route”: “SubQ”, “cycle”: “10-30 days”, “storage”: “”, “level”: “emerging”, “category”: “Cognitive”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Dihexa”, “name”: “Dihexa”, “sub”: “Synaptogenic Peptide | Cognitive Enhancement & Neuroprotection”, “desc”: “Dihexa is a synthetic oligopeptide derived from angiotensin IV that potently enhances cognitive function by promoting synaptogenesis. Originally developed at Washington State University for Alzheimer’s disease, it’s 7 orders of magnitude more potent than BDNF at stimulating new synaptic connections and uniquely crosses the blood-brain barrier.”, “uses”: [“Cognitive”, “Memory Enhancement”, “Learning Acceleration”, “Cognitive Recovery”, “Neuroprotection”, “Neuroplasticity”], “research amount”: “8-10mg oral / 0.5mg/kg IP”, “route”: “Injectable”, “cycle”: “4-8 weeks”, “storage”: “Room temp (oral) / 2-8°C (DMSO stock)”, “level”: “emerging”, “category”: “Cognitive”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “DSIP”, “name”: “DSIP”, “sub”: “Delta Sleep-Inducing Peptide | Sleep & Stress Modulator”, “desc”: “DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) discovered in 1974 in rabbit brain. Originally isolated for its sleep-promoting properties, DSIP has since been found to have diverse neuromodulatory effects including stress reduction, pain modulation, and endocrine regulation, though its exact mechanisms and clinical efficacy remain subjects of ongoing research.”, “uses”: [“Sleep”, “Deep Sleep Enhancement”, “Sleep Efficiency”, “Natural Sleep Architecture”, “Mood”, “Metabolic”], “research amount”: “100-300mcg”, “route”: “Injectable”, “cycle”: “5-10 days”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Sleep”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/dsip/”}, {“abbr”: “Epithalon”, “name”: “Epithalon”, “sub”: “Synthetic Pineal Tetrapeptide | Telomerase Activator & Anti-Aging”, “desc”: “Epitalon (Epithalon, AEDG) is a synthetic tetrapeptide consisting of four amino acids (Ala-Glu-Asp-Gly) based on a naturally occurring pineal gland peptide. Developed by Russian scientist Vladimir Khavinson and studied for over 35 years, Epitalon is primarily researched for its ability to activate telomerase, extend telomeres, and potentially slow cellular aging through multiple mechanisms including melatonin regulation and gene expression modulation. IMPORTANT: Current Western research protocol protocols may be 50-100x higher than necessary due to translation errors from Russian literature.”, “uses”: [“Anti Aging”, “Telomere Extension”, “Cellular Rejuvenation”, “Lifespan Extension”, “Neuroprotection”, “Immunity”], “research amount”: “100-500μg”, “route”: “Injectable”, “cycle”: “10-20 days”, “storage”: “2-8°C”, “level”: “well”, “category”: “Anti-Aging”, “source”: “luvi”, “url”: “https://luviscience.com/product/epithalon-10mg/”}, {“abbr”: “EPO Helix-B”, “name”: “EPO Helix-B”, “sub”: “Erythropoietin Helix-B Surface Peptide”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “1000–5000 mcg”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Performance”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “FBA”, “name”: “Fat Blaster”, “sub”: “Enhanced Lipotropic Blend | L-Carnitine + MIC + B Vitamins + NADH”, “desc”: “Fat Blaster is a lipotropic injection blend combining L-Carnitine, Methionine-Inositol-Choline (MIC), B vitamins (B6, B12), and NADH. This enhanced formulation builds on traditional MIC injections by adding L-Carnitine for fatty acid transport and NADH for cellular energy metabolism. Formulations vary significantly between vendors, with ingredient ratios and concentrations differing. While”, “uses”: [“Fat Oxidation Support”, “Liver Lipid Metabolism”, “Insulin Sensitivity Support”, “Metabolic Function”, “Cellular Energy Production”], “research amount”: “1-2 mL”, “route”: “Injectable”, “cycle”: “4-12 weeks”, “storage”: “2-8°C (refrigerated)”, “level”: “limited”, “category”: “Fat Metabolism, Insulin Sensitivity, Energy & Metabolism”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Follistatin 344”, “name”: “Follistatin 344”, “sub”: “Myostatin Inhibitor | TGF-β Antagonist for Muscle Research”, “desc”: “Follistatin 344 (FS-344) is a naturally occurring glycoprotein that inhibits myostatin and activin A, members of the TGF-β superfamily that suppress muscle growth. The FS-344 gene encodes a 344-amino acid precursor that is cleaved to produce the circulating FS-315 isoform. Gene therapy studies in primates and human clinical trials for”, “uses”: [“Myostatin Inhibition”, “Activin A Blockade”, “Satellite Cell Activation”, “Muscular Dystrophy Research”, “Muscle Wasting Conditions”], “research amount”: “100-200 mcg (anecdotal protocols only)”, “route”: “Injectable”, “cycle”: “10-30 days (anecdotal)”, “storage”: “-20°C (lyophilized); 2-8°C (reconstituted)”, “level”: “emerging”, “category”: “Muscle Growth, Recovery”, “source”: “both”, “url”: “”}, {“abbr”: “FOX”, “name”: “FOXO4-DRI”, “sub”: “Senolytic Peptide | FOXO4-p53 Disruption for Cellular Aging Research”, “desc”: “FOXO4-DRI (FOXO4-D-Retro-Inverso) is a synthetic 46-amino acid peptide designed to selectively eliminate senescent cells -damaged cells that accumulate with age and secrete harmful inflammatory factors (SASP). The peptide uses D-amino acids in reversed sequence, making it resistant to proteolytic degradation while maintaining binding function. FOXO4-DRI works by disrupting the FOXO4-p53”, “uses”: [“Senescent Cell Clearance”, “Tissue Rejuvenation”, “Cellular Health”, “SASP Reduction”], “research amount”: “~25 mg per injection”, “route”: “Injectable”, “cycle”: “5 days per cycle”, “storage”: “-20°C (lyophilized)”, “level”: “emerging”, “category”: “Anti-Aging, Cellular Health, Anti-Inflammatory”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Fragment 176-191”, “name”: “Fragment 176-191”, “sub”: “Advanced Obesity Drug | Modified hGH Fragment 176-191”, “desc”: “AOD-9604 is a modified 17-amino acid fragment of human growth hormone (hGH 176-191) with an added N-terminal tyrosine. It stimulates lipolysis and inhibits lipogenesis without the growth-promoting effects of full hGH. Unlike intact growth hormone, AOD-9604 does not increase IGF-1, affect glucose metabolism, or bind to the GH receptor.”, “uses”: [“Fat Loss”, “Fat Loss / Lipolysis”, “Lipogenesis Inhibition”, “Metabolic Safety”, “Joint”], “research amount”: “250-500mcg”, “route”: “Injectable”, “cycle”: “8-12 weeks”, “storage”: “2-8°C”, “level”: “extensive”, “category”: “Fat Loss”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “GHK-Cu”, “name”: “GHK-Cu”, “sub”: “GHK-Cu (Injectable Form)”, “desc”: “”, “research amount”: “100-200 mcg daily”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “Refrigerated (2-8°C)”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “Ghrelin”, “name”: “Ghrelin”, “sub”: “Ghrelin Peptide Hormone (Acylated)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “1–10 mcg”, “route”: “SubQ”, “cycle”: “2-4 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Metabolic”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “GHRH 1-44”, “name”: “GHRH 1-44”, “sub”: “Growth Hormone Releasing Hormone 1-44”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–200 mcg”, “route”: “SubQ”, “cycle”: “12-24 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Growth Hormone”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “GHRP-1”, “name”: “GHRP-1”, “sub”: “Growth Hormone Releasing Peptide-1”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–300 mcg”, “route”: “SubQ”, “cycle”: “8-12 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Growth Hormone”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “GHRP-2”, “name”: “GHRP-2”, “sub”: “Growth Hormone Releasing Peptide-2”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–300 mcg”, “route”: “SubQ”, “cycle”: “8-12 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Growth Hormone”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “GHRP-6”, “name”: “GHRP-6”, “sub”: “Growth Hormone Releasing Peptide-6”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–300 mcg”, “route”: “SubQ”, “cycle”: “8-12 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Growth Hormone”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “GPL”, “name”: “Glow Protocol”, “sub”: “Multi-Peptide Skin Rejuvenation Complex | Regenerative Blend”, “desc”: “The Glow Protocol is a peptide combination featuring BPC-157, TB-500, and GHK-Cu (Copper Peptide) marketed for skin rejuvenation and anti-aging. While individual components have research backing, combination protocols require careful research protocol consideration to avoid exceeding therapeutic ranges for individual peptides.”, “uses”: [“Skin Rejuvenation”, “Collagen Synthesis”, “Anti-Aging Support”, “Wound Healing”, “Tissue Regeneration”], “research amount”: “Varies by formulation”, “route”: “Injectable”, “cycle”: “8-12 weeks”, “storage”: “2-8°C”, “level”: “limited”, “category”: “Skin Health, Tissue Repair, Cellular Health”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “GLP-2”, “name”: “GLP-2”, “sub”: “Glucagon-Like Peptide-2 (Teduglutide)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “50–100 mcg”, “route”: “SubQ”, “cycle”: “24 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Healing”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “GLU”, “name”: “Glutathione”, “sub”: “Master Antioxidant | Tripeptide | GSH”, “desc”: “Glutathione (GSH) is a tripeptide composed of glutamate, cysteine, and glycine, often called the body’s ‘master antioxidant.’ Found in virtually every cell, it plays critical roles in neutralizing free radicals, detoxifying harmful substances, recycling other antioxidants (vitamins C and E), and supporting immune function. Glutathione levels decline with age and”, “uses”: [“Master Antioxidant”, “Antioxidant Recycling”, “Phase II Liver Support”, “Heavy Metal Binding”, “Lymphocyte Support”], “research amount”: “200-600 mg”, “route”: “Injectable”, “cycle”: “4-8 weeks”, “storage”: “Refrigerated (2-8°C)”, “level”: “well”, “category”: “Antioxidant Support, Detoxification, Immune Function”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Gonadorelin”, “name”: “Gonadorelin”, “sub”: “Gonadorelin Acetate (GnRH Analogue)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–500 mcg”, “route”: “SubQ”, “cycle”: “Ongoing”, “storage”: “”, “level”: “emerging”, “category”: “Hormonal”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “HCG”, “name”: “HCG (Human Chorionic Gonadotropin)”, “sub”: “Gonadotropin Hormone | LH Receptor Agonist”, “desc”: “Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone naturally produced by the placenta during pregnancy. It consists of two subunits: an alpha subunit identical to other pituitary hormones (LH, FSH, TSH) and a unique beta subunit that confers HCG’s specific biological activity. Pharmaceutical HCG is derived from the urine of pregnant women or produced recombinantly. It binds to and activates LH receptors, making it valuable for treating hypogonadism, infertility, and cryptorchidism. In TRT protocols, HCG is commonly used to maintain testicular function, preserve fertility, and prevent testicular atrophy.”, “uses”: [“Hypogonadotropic Hypogonadism”, “Testosterone Support”, “Fertility Preservation”, “TRT Adjunct”, “Cryptorchidism Treatment”], “research amount”: “250-1500 IU (varies by indication)”, “route”: “Injectable”, “cycle”: “Ongoing with TRT / 3-6 months fertility protocols”, “storage”: “2-8°C after reconstitution”, “level”: “extensive”, “category”: “Growth Hormone, Recovery, Body Composition”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Hexarelin”, “name”: “Hexarelin (Examorelin)”, “sub”: “Hexapeptide GHRP | Growth Hormone Release & Cardioprotection”, “desc”: “Hexarelin (also known as Examorelin) is a synthetic hexapeptide growth hormone releasing peptide (GHRP) and one of the most potent GH secretagogues studied. Derived from GHRP-6 by Mediolanum Farmaceutici, it stimulates growth hormone release through the ghrelin receptor (GHS-R1a) and uniquely binds to cardiac CD36 receptors, providing cardioprotective effects independent of GH release. Hexarelin reached Phase II clinical trials for growth hormone deficiency and congestive heart failure but was discontinued in 2005 for strategic reasons. Research demonstrates its potential in cardioprotection, neuroprotection, and metabolic regulation.”, “uses”: [“Growth Hormone Release”, “IGF-1 Elevation”, “Pulsatile GH Pattern”, “Cardioprotection”, “Anti-Fibrotic Effects”], “research amount”: “100-300 mcg daily (divided research amounts)”, “route”: “Injectable”, “cycle”: “8-16 weeks”, “storage”: “2-8°C”, “level”: “well”, “category”: “Hormonal Balance, Cardiovascular, Neurological Support”, “source”: “both”, “url”: “”}, {“abbr”: “HGH Fragment”, “name”: “HGH Fragment 176-191”, “sub”: “Menopause & Vitality | 191aa Recombinant Growth Hormone”, “desc”: “HGH Fragment 176-191 is a modified form of amino acids 176-191 of the human growth hormone polypeptide. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis without affecting blood sugar or tissue growth. Research focuses on fat loss, particularly stubborn abdominal fat.”, “uses”: [“Fat Loss”, “Lipolysis”, “Metabolic Enhancement”, “Body Composition”], “research amount”: “1-4 IU (0.33-1.33 mg) daily”, “route”: “Injectable”, “cycle”: “Ongoing / 3-6 month cycles”, “storage”: “2-8°C (refrigerated)”, “level”: “Well Researched”, “category”: “Hormone Balance”, “url”: “https://luviscience.com/product/hgh-fragment/”, “source”: “luvi”}, {“abbr”: “Humanin”, “name”: “Humanin”, “sub”: “Humanin Mitochondrial Peptide”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–500 mcg”, “route”: “SubQ”, “cycle”: “4-12 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Vitality After 40”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “IGF-1 LR3”, “name”: “IGF-1 LR3”, “sub”: “Modified Growth Factor Analog | Research Chemical Only”, “desc”: “IGF-1 LR3 is a synthetic 83-amino acid analog of human insulin-like growth factor-1 that has never been approved for human use in any country. Despite approximately 3x greater potency than native IGF-1 with a 20-30 hour half-life due to reduced IGF-binding protein interaction, no human clinical trials have ever been conducted. The compound is prohibited in competitive sports, carries significant risks including severe hypoglycemia and cancer proliferation, and remains strictly a research chemical for laboratory use only.”, “uses”: [“Muscle Growth”, “Muscle Hypertrophy”, “Anti-Catabolic Effects”, “Hyperplasia Induction”, “Tissue Repair”, “Metabolic”], “research amount”: “20-100mcg (research range)”, “route”: “Injectable”, “cycle”: “4-6 weeks maximum”, “storage”: “-20°C to -80°C (lyophilized)”, “level”: “limited”, “category”: “Muscle”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/igf-1-lr3/”}, {“abbr”: “IGF-2”, “name”: “IGF-2”, “sub”: “Insulin-like Growth Factor 2”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “20–100 mcg”, “route”: “SubQ”, “cycle”: “4-6 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Growth Hormone”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Insulin B9-23”, “name”: “Insulin B9-23”, “sub”: “Insulin B Chain Fragment B9-23”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–500 mcg”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Metabolic”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Ipamorelin”, “name”: “Ipamorelin”, “sub”: “Growth Hormone Secretagogue | Selective GHRP”, “desc”: “Ipamorelin is a selective growth hormone releasing peptide (GHRP) that stimulates natural growth hormone production from the pituitary gland. Known for its clean profile with minimal side effects on cortisol and prolactin levels, making it ideal for body composition, recovery, and anti-aging applications.”, “uses”: [“Growth Hormone”, “Natural GH Stimulation”, “IGF-1 Enhancement”, “Anti-Aging Benefits”, “Body Composition”, “Recovery”], “research amount”: “200-300mcg”, “route”: “Injectable”, “cycle”: “3-6 months”, “storage”: “2-8°C”, “level”: “well”, “category”: “Growth Hormone”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/ipamorelin/”}, {“abbr”: “KIS”, “name”: “Kisspeptin”, “sub”: “KISS1 Gene Product | Reproductive Neuropeptide”, “desc”: “Kisspeptin is a family of neuropeptides encoded by the KISS1 gene that acts as a master regulator of the reproductive system. It potently stimulates gonadotropin-releasing hormone (GnRH) neurons, making it essential for puberty initiation, fertility, and reproductive function. Research explores its therapeutic potential for infertility, low libido, and reproductive disorders.”, “uses”: [“Hypogonadotropic Hypogonadism”, “IVF Ovulation Trigger”, “Hypothalamic Amenorrhea”, “Hypoactive Sexual Desire Disorder”, “Sexual Brain Processing”], “research amount”: “100-200mcg”, “route”: “Injectable”, “cycle”: “2-4 weeks”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Reproductive Health, Sexual Health, Metabolism Support”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Kisspeptin-10”, “name”: “Kisspeptin-10”, “sub”: “KISS1 Gene Product | Reproductive Neuropeptide”, “desc”: “Kisspeptin is a family of neuropeptides encoded by the KISS1 gene that acts as a master regulator of the reproductive system. It potently stimulates gonadotropin-releasing hormone (GnRH) neurons, making it essential for puberty initiation, fertility, and reproductive function. Research explores its therapeutic potential for infertility, low libido, and reproductive disorders.”, “uses”: [“Reproductive”, “Hypogonadotropic Hypogonadism”, “IVF Ovulation Trigger”, “Hypothalamic Amenorrhea”, “Sexual”, “Metabolic”], “research amount”: “100-200mcg”, “route”: “Injectable”, “cycle”: “2-4 weeks”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Hormonal”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Kisspeptin-54”, “name”: “Kisspeptin-54”, “sub”: “KISS1 Gene Product | Reproductive Neuropeptide”, “desc”: “Kisspeptin is a family of neuropeptides encoded by the KISS1 gene that acts as a master regulator of the reproductive system. It potently stimulates gonadotropin-releasing hormone (GnRH) neurons, making it essential for puberty initiation, fertility, and reproductive function. Research explores its therapeutic potential for infertility, low libido, and reproductive disorders.”, “uses”: [“Reproductive”, “Hypogonadotropic Hypogonadism”, “IVF Ovulation Trigger”, “Hypothalamic Amenorrhea”, “Sexual”, “Metabolic”], “research amount”: “100-200mcg”, “route”: “Injectable”, “cycle”: “2-4 weeks”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Hormonal”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “KK-10”, “name”: “KK-10”, “sub”: “Four-Peptide Regenerative Blend | GHK-Cu + TB-500 + BPC-157 + KPV”, “desc”: “KLOW is a research peptide combination that builds upon the GLOW protocol by adding KPV for enhanced anti-inflammatory effects. This 80mg blend typically contains 50mg GHK-Cu, 10mg TB-500, 10mg BPC-157, and 10mg KPV in a 5:1:1:1 ratio. While individual components have varying levels of research support, no clinical trials have examined this specific four-peptide combination. The protocol remains investigational with theoretical benefits based on complementary mechanisms.”, “uses”: [“Wound Healing”, “Multi-Modal Healing”, “Enhanced Tolerability”, “KPV may reduce injection site reactions compared to GLOW”, “Convenience Factor”, “Single injection versus four separate peptides”, “Recovery”, “Anti Inflammatory”], “research amount”: “2-3.2mg total blend”, “route”: “Injectable”, “cycle”: “4-6 weeks reported”, “storage”: “2-8°C”, “level”: “limited”, “category”: “Antimicrobial”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “KPL”, “name”: “KLOW Protocol”, “sub”: “Anti-Inflammatory Tripeptide | Alpha-MSH Fragment”, “desc”: “KPV is a potent anti-inflammatory tripeptide derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). This small but powerful peptide exhibits remarkable anti-inflammatory and antimicrobial properties without the pigmentation effects of full α-MSH. KPV has shown particular promise for inflammatory bowel diseases, skin conditions, and immune modulation through its ability to penetrate cells and interact directly with inflammatory signaling pathways.”, “uses”: [“Multi-Modal Healing”, “Enhanced Tolerability”, “Convenience Factor”, “Post-Surgical Recovery”, “Sports Injury Support”], “research amount”: “200-500mcg”, “route”: “Injectable”, “cycle”: “4-8 weeks”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Wound Healing, Recovery, Anti-Inflammatory”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “KPV”, “name”: “KPV”, “sub”: “Anti-Inflammatory Tripeptide | Alpha-MSH Fragment”, “desc”: “KPV is a potent anti-inflammatory tripeptide derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). This small but powerful peptide exhibits remarkable anti-inflammatory and antimicrobial properties without the pigmentation effects of full α-MSH. KPV has shown particular promise for inflammatory bowel diseases, skin conditions, and immune modulation through its ability”, “uses”: [“Systemic Inflammation”, “Autoimmune Modulation”, “Joint Inflammation”, “IBD Support”, “Intestinal Barrier”], “research amount”: “200-500mcg”, “route”: “Injectable”, “cycle”: “4-8 weeks”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Anti-Inflammatory, Gut Health, Immune Function”, “source”: “both”, “url”: “”}, {“abbr”: “L-Carnitine”, “name”: “L-Carnitine”, “sub”: “Amino Acid Derivative | Energy & Fat Metabolism”, “desc”: “L-Carnitine (levocarnitine) is a naturally occurring amino acid derivative essential for transporting long-chain fatty acids into mitochondria for energy production via beta-oxidation. Synthesized endogenously from lysine and methionine, it plays critical roles in energy metabolism, particularly in high-energy tissues like heart, brain, and skeletal muscle. FDA approved as Carnitor® for”, “uses”: [“Fat Metabolism & Hormone Balance”, “Mitochondrial Energy Support”, “Heart Health”, “Cognitive Function (ALCAR)”, “Exercise Recovery”], “research amount”: “500-2000mg”, “route”: “Injectable”, “cycle”: “Ongoing or 8-12 weeks”, “storage”: “Room temp (unopened) / 2-8°C (opened)”, “level”: “well”, “category”: “Hormone Balance, Metabolism Support, Cardiovascular”, “source”: “both”, “url”: “”}, {“abbr”: “LEAP-2”, “name”: “LEAP-2”, “sub”: “Liver-Expressed Antimicrobial Peptide 2”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “500–2000 mcg”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Metabolic”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Leu-Enkephalin”, “name”: “Leu-Enkephalin”, “sub”: “Leucine-Enkephalin (Endogenous Opioid)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “50–500 mcg”, “route”: “SubQ”, “cycle”: “As needed”, “storage”: “”, “level”: “emerging”, “category”: “Pain”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “LIP”, “name”: “Lipo-C”, “sub”: “Lipotropic Injection | MIC + B Vitamins”, “desc”: “Lipo-C is a lipotropic injection containing Methionine, Inositol, Choline (MIC), and B vitamins that support fat metabolism and liver function. These nutrients act as methyl donors and lipotropic agents, assisting in the breakdown and transport of fats. While individual components have documented metabolic roles, clinical evidence for the combined injection”, “uses”: [“Liver Function Support”, “Methylation Support”, “Insulin Sensitivity”, “Fat Metabolism Support”, “Modest Effects”], “research amount”: “1-2 mL”, “route”: “Injectable”, “cycle”: “4-12 weeks”, “storage”: “Room temp or refrigerated”, “level”: “limited”, “category”: “Metabolic Health, Fat Loss, Energy & Metabolism”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Liraglutide”, “name”: “Liraglutide”, “sub”: “Liraglutide (GLP-1 Receptor Agonist)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “600–3000 mcg”, “route”: “SubQ”, “cycle”: “Ongoing”, “storage”: “”, “level”: “emerging”, “category”: “Hormone Balance”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “LL-37”, “name”: “LL-37”, “sub”: “LL-37 (Injectable Form)”, “desc”: “”, “research amount”: “250 mcg daily”, “route”: “SubQ”, “cycle”: “4-12 weeks”, “storage”: “Refrigerated (2-8°C)”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “MAZ”, “name”: “Mazdutide”, “sub”: “Dual GLP-1/Glucagon Receptor Agonist | Hormone Balance & Diabetes”, “desc”: “Mazdutide (IBI362/LY3305677) is a first-in-class dual glucagon-like peptide-1 (GLP-1) and glucagon receptor agonist, and a synthetic analog of oxyntomodulin. Unlike dual agonist research compounds which targets GIP/GLP-1, mazdutide uniquely combines GLP-1’s appetite suppression with glucagon’s ability to stimulate thermogenesis and increase energy expenditure. Phase 3 trials (GLORY-1, GLORY-2) have demonstrated up to 20%”, “uses”: [“Severe Obesity Management”, “Metabolic Syndrome Improvement”, “Liver Fat Reduction”, “Type 2 Diabetes Management”, “Dual Endpoint Achievement”], “research amount”: “3-9mg weekly”, “route”: “Injectable”, “cycle”: “48-60+ weeks”, “storage”: “2-8°C / -20°C (lyophilized)”, “level”: “extensive”, “category”: “Hormone Balance, Diabetes, Cardiovascular”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Melanotan II”, “name”: “Melanotan II”, “sub”: “Synthetic Melanocortin Peptide | Tanning & Sexual Function”, “desc”: “Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that stimulates melanin production for skin tanning and has additional effects on sexual arousal and appetite suppression. Originally developed at the University of Arizona as a sunless tanning agent, it has gained attention for its dual effects on pigmentation and sexual function through melanocortin receptor activation.”, “uses”: [“Skin Health”, “UV-Free Tanning”, “Photoprotection”, “Even Pigmentation”, “Hormonal”, “Metabolic”], “research amount”: “0.25-1mg”, “route”: “Injectable”, “cycle”: “4-8 weeks”, “storage”: “2-8°C”, “level”: “well”, “category”: “Tanning”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/melanotan-mt-ii/”}, {“abbr”: “MK-677”, “name”: “MK-677”, “sub”: “MK-677 (Injectable Form)”, “desc”: “”, “research amount”: “10-25 mg daily”, “route”: “SubQ”, “cycle”: “8-12 weeks”, “storage”: “Room temperature”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “MOTS-c”, “name”: “MOTS-c”, “sub”: “Mice | Daily study handling during pregnancy | Throughout pregnancy | Alleviated hyperglycemia, improved maternal-fetal outcomes”, “desc”: “MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded by the mitochondrial genome. It acts as a mitohormone that regulates metabolic homeostasis, enhances insulin sensitivity, and promotes vitality after 40. MOTS-c operates through the Folate-AICAR-AMPK pathway and can translocate to the nucleus under metabolic stress to regulate gene expression.”, “uses”: [“Metabolic”, “Insulin Resistance”, “Type 2 Diabetes”, “Obesity Prevention”, “Anti Aging”, “Exercise”], “research amount”: “5-15mg”, “route”: “Injectable”, “cycle”: “4-12 weeks”, “storage”: “2-8°C”, “level”: “extensive”, “category”: “Quick Start Guide”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/mots-c/”}, {“abbr”: “NAD+”, “name”: “NAD+ (Nicotinamide Adenine Dinucleotide)”, “sub”: “Essential Cellular Coenzyme | Anti-Aging Therapy”, “desc”: “NAD+ is a coenzyme found in all living cells, essential for cellular energy production and DNA repair. NAD+ levels decline with age, and supplementation is researched for its potential anti-aging, cognitive enhancement, and metabolic benefits. It plays a critical role in mitochondrial function and sirtuin activation.”, “uses”: [“Anti-Aging”, “Energy & Metabolism”, “Cognitive Enhancement”, “DNA Repair”, “Mitochondrial Health”], “research amount”: “100-1000mg”, “route”: “Injectable”, “cycle”: “4-12 weeks”, “storage”: “2-8°C”, “level”: “extensive”, “category”: “Vitality After 40”, “url”: “https://luviscience.com/product/nad-500mg/”, “source”: “luvi”}, {“abbr”: “NAP”, “name”: “NAP”, “sub”: “NAP (Injectable Form)”, “desc”: “”, “research amount”: “10-20 mg daily”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “Refrigerated (2-8°C)”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “NC-17”, “name”: “NC-17”, “sub”: “NC-17 (Injectable Form)”, “desc”: “”, “research amount”: “200-500 mcg daily”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “Refrigerated (2-8°C)”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “Oral GLP research compounds”, “name”: “Oral GLP research compounds”, “sub”: “GLP-1 Receptor Agonist | Hormone Balance & Diabetes”, “desc”: “GLP research compounds is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist FDA-approved for type 2 diabetes management (as Ozempic) and chronic weight management (as Wegovy). With over 17,000 participants in clinical trials, it demonstrates significant hormone balance potential (average 15-20% body weight reduction) through appetite suppression, slowed gastric emptying, and enhanced glucose control.”, “uses”: [“Hormone Balance”, “Clinically Significant Weight Reduction”, “Appetite and Craving Control”, “Sustained Weight Maintenance”, “Diabetes”, “Metabolic”], “research amount”: “0.25-2.4mg weekly”, “route”: “Injectable”, “cycle”: “Ongoing as prescribed”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Hormone Balance”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “OXY”, “name”: “Oxytocin”, “sub”: “Neurohypophysial Peptide | Social Bonding & Reproductive Hormone”, “desc”: “Oxytocin is a nine-amino-acid peptide hormone and neuropeptide naturally produced in the hypothalamus and released by the posterior pituitary. Known as the \”love hormone\” or \”bonding hormone,\” it plays fundamental roles in social bonding, trust, empathy, sexual reproduction, childbirth, and lactation. Synthetic oxytocin (Pitocin/Syntocinon) is FDA-approved for labor induction and”, “uses”: [“Social Bonding and Trust”, “Autism Spectrum Disorders”, “Social Anxiety”, “PTSD Therapy Augmentation”, “Anxiety and Depression”], “research amount”: “10-20 units (obstetric)”, “route”: “Injectable”, “cycle”: “Single use (clinical)”, “storage”: “2-8°C”, “level”: “extensive”, “category”: “Social, Mental, Reproductive Health”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “P21”, “name”: “P21”, “sub”: “P21 (Injectable Form)”, “desc”: “”, “research amount”: “200-500 mcg daily”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “Refrigerated (2-8°C)”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “PE”, “name”: “PE-22-28 (Mini-Spadin)”, “sub”: “TREK-1 Channel Blocker | Shortened Spadin Analog”, “desc”: “PE-22-28, also known as Mini-Spadin, is a synthetic heptapeptide derived from positions 22-28 of the parent peptide Spadin. Spadin itself originates from the propeptide (PE) released during the maturation of sortilin/neurotensin receptor-3 (NTSR3). PE-22-28 is a potent and selective antagonist of TREK-1 (TWIK-Related Potassium Channel-1), a two-pore domain potassium channel implicated in depression, neuroprotection, and pain modulation. With an IC50 of 0.12 nM, PE-22-28 demonstrates approximately 300-500 fold greater affinity for TREK-1 compared to full-length Spadin. Preclinical research shows rapid antidepressant effects within 4 days, accompanied by neurogenesis and synaptogenesis in the hippocampus – significantly faster than conventional SSRIs.”, “uses”: [“Depression Research”, “Neurogenesis / Cognitive”, “Anxiety Research”, “Neuroprotection / Stroke”], “research amount”: “50-200 mcg (research protocols)”, “route”: “Injectable”, “cycle”: “4-8 weeks (research protocols)”, “storage”: “2-8°C (refrigerated)”, “level”: “emerging”, “category”: “Mood Support, Cognitive Enhancement, Anxiety Relief”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “PEG”, “name”: “PEG-MGF”, “sub”: “Pegylated Mechano Growth Factor | IGF-1 Splice Variant”, “desc”: “PEG-MGF (Pegylated Mechano Growth Factor) is a modified form of the IGF-1 splice variant MGF (IGF-1Ec), with polyethylene glycol attached to extend its half-life from minutes to hours. MGF is naturally expressed in muscle tissue following mechanical stress or injury, where it activates satellite cells to support muscle repair. A”, “uses”: [“Satellite Cell Activation”, “Delayed Senescence”, “Enhanced Fusion Potential”, “Tendon Healing”, “Bone Regeneration”], “research amount”: “200-400mcg”, “route”: “Injectable”, “cycle”: “4-8 weeks”, “storage”: “2-8°C (reconstituted)”, “level”: “limited”, “category”: “Muscle Repair, Tissue Regeneration, Recovery”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “PIN”, “name”: “Pinealon”, “sub”: “Synthetic Tripeptide | Neuroprotection & Cognitive Enhancement”, “desc”: “Pinealon (Glu-Asp-Arg/EDR) is a synthetic tripeptide bioregulator developed in Russia that demonstrates unique DNA-interaction capabilities for neuroprotection and cognitive enhancement. Research suggests benefits for traumatic brain injury recovery, age-related cognitive decline, and cellular aging processes through direct gene expression modulation.”, “uses”: [“Traumatic Brain Injury Recovery”, “Cellular Neuroprotection”, “Stroke Recovery Support”, “Memory Enhancement”, “NMDA Receptor Expression”], “research amount”: “5mg”, “route”: “Injectable”, “cycle”: “20 days”, “storage”: “2-8°C”, “level”: “well”, “category”: “Neurological Support, Cognitive Enhancement, Anti-Aging”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “PN-1 Peptide”, “name”: “PN-1 Peptide”, “sub”: “Protease Nexin-1 Healing Peptide”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “200–800 mcg”, “route”: “SubQ”, “cycle”: “6-12 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Healing”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “PRO”, “name”: “Prostamax”, “sub”: “Synthetic Tetrapeptide | Prostate Bioregulator”, “desc”: “Prostamax (Lys-Glu-Asp-Pro/KEDP) is a synthetic tetrapeptide bioregulator from the Khavinson peptide family that demonstrates prostate-specific tissue effects. Preclinical research shows anti-inflammatory and tissue-protective properties in chronic prostatitis models, with emerging interest in epigenetic chromatin regulation and anti-aging applications. Human clinical trial data remains limited.”, “uses”: [“Chronic Prostatitis Management”, “Tissue Regeneration”, “Superior to Conventional Agents”, “Chromatin Decondensation”, “Epigenetic Modulation”], “research amount”: “0.5-1mg”, “route”: “Injectable”, “cycle”: “10-20 days”, “storage”: “2-8°C”, “level”: “limited”, “category”: “Prostate Health, Anti-Aging, Immune Support”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “PT-141”, “name”: “PT-141”, “sub”: “Melanocortin Receptor Agonist | Sexual Dysfunction Treatment”, “desc”: “PT-141 (Bremelanotide) is an FDA-approved synthetic peptide that acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R receptors in the central nervous system. Unlike traditional ED medications that work through vascular mechanisms, PT-141 directly influences sexual arousal pathways in the brain, making it effective for both male and female sexual dysfunction.”, “uses”: [“Hormonal”, “Hypoactive Sexual Desire Disorder (HSDD)”, “Erectile Dysfunction”, “Female Sexual Arousal Disorder”, “Improves physiological and subjective arousal measures”, “Mood”, “Metabolic”], “research amount”: “1.75mg”, “route”: “Injectable”, “cycle”: “No cycling required”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Sexual Health”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/pt-141/”}, {“abbr”: “PTH 1-34”, “name”: “PTH 1-34”, “sub”: “Parathyroid Hormone Fragment 1-34 (Teriparatide)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “20–40 mcg”, “route”: “SubQ”, “cycle”: “24 months max”, “storage”: “”, “level”: “emerging”, “category”: “Performance”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Relaxin-2”, “name”: “Relaxin-2”, “sub”: “Relaxin-2 Peptide Hormone”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “10–80 mcg”, “route”: “IV”, “cycle”: “48 hours”, “storage”: “”, “level”: “emerging”, “category”: “Cardiovascular”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Retatrutide”, “name”: “Retatrutide”, “sub”: “Triple GLP-1/GIP/Glucagon Agonist | Hormone Balance & Diabetes”, “desc”: “Retatrutide (LY3437943) is a novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors. Phase III TRIUMPH-4 trial (Dec 2025) achieved 28.7% hormone balance (71.2 lbs) at 68 weeks with 12mg research amount – the highest recorded for any obesity medication. Currently in late-stage Phase III development by Eli Lilly with FDA approval expected 2026-2027.”, “uses”: [“Hormone Balance”, “Superior Weight Reduction”, “Sustained Weight Management”, “Triple Mechanism Obesity Treatment”, “Diabetes”, “Cardiovascular”], “research amount”: “0.5-12 mg weekly”, “route”: “Injectable”, “cycle”: “Continuous therapy”, “storage”: “2-8°C”, “level”: “extensive”, “category”: “Hormone Balance”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/glp-3-ret-5mg-retatrutide/”}, {“abbr”: “Selank”, “name”: “Selank”, “sub”: “Synthetic Tuftsin Analog | Anxiolytic & Nootropic Peptide”, “desc”: “Selank is a synthetic heptapeptide analog of the naturally occurring immune peptide tuftsin, developed by the Russian Academy of Sciences. This anxiolytic and nootropic peptide has been extensively studied for its ability to reduce anxiety, enhance cognitive function, and modulate immune responses without the side effects associated with traditional benzodiazepines. Selank works through complex interactions with GABAergic, serotonergic, and dopaminergic neurotransmitter systems, offering a unique mechanism for stress reduction and cognitive enhancement.”, “uses”: [“Anxiety”, “Generalized Anxiety Disorder”, “Post-Traumatic Stress Disorder”, “Social Anxiety and Performance Stress”, “Cognitive”, “Immune”], “research amount”: “250-500mcg daily”, “route”: “Injectable”, “cycle”: “2-8 weeks”, “storage”: “2-8°C”, “level”: “well”, “category”: “Cognitive”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “GLP research compounds”, “name”: “GLP research compounds”, “sub”: “GLP-1 Receptor Agonist | Hormone Balance & Diabetes”, “desc”: “GLP research compounds is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist FDA-approved for type 2 diabetes management (as Ozempic) and chronic weight management (as Wegovy). With over 17,000 participants in clinical trials, it demonstrates significant hormone balance potential (average 15-20% body weight reduction) through appetite suppression, slowed gastric emptying, and enhanced glucose control.”, “uses”: [“Hormone Balance”, “Clinically Significant Weight Reduction”, “Appetite and Craving Control”, “Sustained Weight Maintenance”, “Diabetes”, “Metabolic”], “research amount”: “0.25-2.4mg weekly”, “route”: “Injectable”, “cycle”: “Ongoing as prescribed”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Hormone Balance”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Semax”, “name”: “Semax”, “sub”: “Semax (Injectable Form)”, “desc”: “”, “research amount”: “200-500 mcg daily”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “Refrigerated (2-8°C)”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “SER”, “name”: “Sermorelin”, “sub”: “GHRH 1-29 Analog | Growth Hormone Releasing Hormone”, “desc”: “Sermorelin acetate is a 29-amino acid synthetic analog of human growth hormone-releasing hormone (GHRH) originally FDA-approved in 1997 for pediatric growth hormone deficiency. Despite discontinuation in 2008 for manufacturing reasons, it maintains excellent safety profile and stimulates natural growth hormone production while preserving physiological pulsatile patterns.”, “uses”: [“Lean Body Mass Enhancement”, “IGF-1 Mediated Growth”, “Athletic Performance Support”, “Age-Related GH Decline Reversal”, “Body Composition Improvement”], “research amount”: “200-300 mcg”, “route”: “Injectable”, “cycle”: “3-6 months”, “storage”: “2-8°C”, “level”: “well”, “category”: “Muscle Growth, Anti-Aging, Hormonal Balance”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “SHLP2”, “name”: “SHLP2”, “sub”: “Small Humanin-Like Peptide 2”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “50–200 mcg”, “route”: “SubQ”, “cycle”: “4-12 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Vitality After 40”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “SS-31”, “name”: “SS-31”, “sub”: “Mitochondrial-Targeted Peptide | Cardiolipin Protector”, “desc”: “SS-31, also known as Elamipretide or Bendavia, is a small aromatic-cationic tetrapeptide that selectively targets mitochondria. Unlike traditional antioxidants, SS-31 specifically binds to cardiolipin in the inner mitochondrial membrane, protecting it from oxidative damage and improving cellular energy production. This unique mechanism makes it particularly promising for age-related conditions, heart disease, and mitochondrial disorders.”, “uses”: [“Mitochondrial”, “Enhanced ATP Production”, “Oxidative Stress Reduction”, “Protects against reactive oxygen species at the source”, “Mitochondrial Disease Support”, “Shows promise for various mitochondrial disorders”, “Cardiovascular”, “Anti Aging”], “research amount”: “5-40mg”, “route”: “Injectable”, “cycle”: “4-12 weeks”, “storage”: “2-8°C”, “level”: “emerging”, “category”: “Vitality After 40”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “SS”, “name”: “SS-31 (Elamipretide)”, “sub”: “Mitochondrial-Targeted Peptide | Cardiolipin Protector”, “desc”: “SS-31, also known as Elamipretide or Bendavia, is a small aromatic-cationic tetrapeptide that selectively targets mitochondria. Unlike traditional antioxidants, SS-31 specifically binds to cardiolipin in the inner mitochondrial membrane, protecting it from oxidative damage and improving cellular energy production. This unique mechanism makes it particularly promising for age-related conditions, heart disease, and mitochondrial disorders.”, “uses”: [“Enhanced ATP Production”, “Oxidative Stress Reduction”, “Mitochondrial Disease Support”, “Cardiac Protection”, “Heart Failure Support”], “research amount”: “5-40mg”, “route”: “Injectable”, “cycle”: “4-12 weeks”, “storage”: “2-8°C”, “level”: “extensive”, “category”: “Mitochondrial, Cardiovascular, Anti-Aging”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Substance P”, “name”: “Substance P”, “sub”: “Substance P Neuropeptide”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “1–10 mcg”, “route”: “SubQ”, “cycle”: “Research only”, “storage”: “”, “level”: “emerging”, “category”: “Pain”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “SUR”, “name”: “Survodutide”, “sub”: “Dual GLP-1/Glucagon Receptor Agonist | Hormone Balance & Diabetes”, “desc”: “Survodutide (BI 456906) is an investigational dual glucagon receptor (GCGR) and GLP-1 receptor (GLP-1R) agonist designed for once-weekly subcutaneous study handling. This 29-amino acid peptide with C18 fatty acid acylation represents a novel approach to metabolic disease treatment by simultaneously targeting both energy intake reduction (via GLP-1R) and energy expenditure increase”, “uses”: [“Obesity Without Diabetes”, “Obesity With Type 2 Diabetes”, “Sustained Weight Management”, “Metabolic Dysfunction-Associated Steatohepatitis (MASH)”, “Liver Fat Reduction”], “research amount”: “0.6-6.0mg”, “route”: “Injectable”, “cycle”: “24-76+ weeks”, “storage”: “2-8°C”, “level”: “extensive”, “category”: “Hormone Balance, Metabolism Support, Cardiovascular”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “TB-4 Fragment”, “name”: “TB-4 Fragment”, “sub”: “Thymosin Beta-4 Fragment (Ac-SDKP)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “200–1000 mcg”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Healing”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “TB-500”, “name”: “TB-500”, “sub”: “Ac-LKKTETQ | Synthetic Fragment (17-23) of Thymosin Beta-4”, “desc”: “TB-500 is a synthetic 7-amino acid fragment (Ac-LKKTETQ) corresponding to the active actin-binding region (positions 17-23) of thymosin beta-4. Originally developed for veterinary use in horses, this fragment retains tissue repair and anti-inflammatory properties while being more stable than the full peptide. Banned by WADA for its performance-enhancing effects”, “uses”: [“Tissue Repair”, “Muscle Regeneration”, “Tendon & Ligament Healing”, “Wound Healing”, “Athletic Recovery”, “Neurological”], “research amount”: “2-5mg”, “route”: “Injectable”, “cycle”: “6-8 weeks”, “storage”: “2-6°C”, “level”: “well”, “category”: “Healing”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/tb500/”}, {“abbr”: “Tesamorelin”, “name”: “Tesamorelin”, “sub”: “GHRH Analog | Visceral Fat Reduction”, “desc”: “Tesamorelin is an FDA-approved synthetic growth hormone-releasing hormone (GHRH) analog designed for treating HIV-associated lipodystrophy. This 44-amino acid peptide with a trans-3-hexenoic acid modification selectively reduces visceral adipose tissue while preserving subcutaneous fat, making it unique among growth hormone therapies.”, “uses”: [“Hormone Balance”, “HIV-Associated Lipodystrophy”, “Selective Visceral Fat Targeting”, “Sustained Fat Loss”, “Metabolic”, “Muscle Growth”], “research amount”: “1.4-2 mg”, “route”: “Injectable”, “cycle”: “Continuous”, “storage”: “Powder: 2-8°C | Reconstituted: 20-25°C”, “level”: “emerging”, “category”: “Fat Loss”, “source”: “peptide.locker”, “url”: “https://luviscience.com/product/tesamorelin/”}, {“abbr”: “Tesofensine”, “name”: “Tesofensine”, “sub”: “Tesofensine (Injectable Form)”, “desc”: “”, “research amount”: “0.25-0.5 mg daily”, “route”: “SubQ”, “cycle”: “8-12 weeks”, “storage”: “Room temperature”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “Thymalin”, “name”: “Thymalin”, “sub”: “Zinc-Dependent Thymic Nonapeptide | Immune Modulation & Anti-Inflammatory”, “desc”: “Thymulin (also known as Serum Thymic Factor or FTS – Facteur Thymique Sérique) is a 9-amino acid metallopeptide hormone produced exclusively by thymic epithelial cells. First characterized by Bach and colleagues in 1977, thymulin is unique in requiring zinc binding (1:1 equimolecular ratio) for biological activity. The zinc-thymulin complex adopts a specific three-dimensional conformation essential for its immunomodulatory functions, including T-cell differentiation, NK cell enhancement, and suppressor T-cell regulation. Beyond immune functions, thymulin demonstrates potent anti-inflammatory and analgesic properties through inhibition of NF-κB, p38 MAPK, and pro-inflammatory cytokines. Serum thymulin levels decline progressively with age (peaking in pre-adolescence), contributing to immunosenescence. Research shows promise in lung diseases, neuropathic pain, and age-related immune dysfunction, though human clinical trials remain limited.”, “uses”: [“Immunity”, “T-Cell Differentiation”, “Suppressor T-Cell Enhancement”, “NK Cell Activation”, “Inflammation”, “Anti Aging”, “Neuroprotection”], “research amount”: “1-5 mg”, “route”: “Injectable”, “cycle”: “5-10 days”, “storage”: “-20°C (lyophilized)”, “level”: “emerging”, “category”: “Immune”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Thymopentin”, “name”: “Thymopentin”, “sub”: “Thymopentin TP-5 (Thymopoietin Fragment)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “1000–5000 mcg”, “route”: “SubQ”, “cycle”: “4-12 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Immune”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Thymosin Alpha-1”, “name”: “Thymosin Alpha-1”, “sub”: “Synthetic Thymic Hormone | Immune System Modulation”, “desc”: “Thymosin Alpha 1 (Ta1/Thymalfasin/Zadaxin) is a synthetic 28-amino acid peptide identical to the naturally occurring thymic hormone. With over 11,000 patients studied across 30+ clinical trials, it holds FDA orphan drug designations for four conditions and is approved in 35+ countries worldwide. Ta1 demonstrates exceptional safety with less than 1% serious adverse events while providing comprehensive immune system modulation.”, “uses”: [“Immunity”, “Primary Immunodeficiencies”, “Vaccine Response Enhancement”, “HIV/AIDS Immune Support”, “Inflammation”, “Recovery”, “Anti Aging”, “Cellular”], “research amount”: “1.6mg”, “route”: “Injectable”, “cycle”: “6 months”, “storage”: “2-6°C”, “level”: “well”, “category”: “Immune”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “Thymosin Beta-10”, “name”: “Thymosin Beta-10”, “sub”: “Thymosin Beta-10 Actin-Sequestering Peptide”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “200–1000 mcg”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “”, “level”: “emerging”, “category”: “Healing”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “THY”, “name”: “Thymulin”, “sub”: “Humans | EPC pre-treatment with Tβ4 | Single transplantation | Improved cardiac function compared to control”, “desc”: “Thymulin (also known as Serum Thymic Factor or FTS – Facteur Thymique Sérique) is a 9-amino acid metallopeptide hormone produced exclusively by thymic epithelial cells. First characterized by Bach and colleagues in 1977, thymulin is unique in requiring zinc binding (1:1 equimolecular ratio) for biological activity. The zinc-thymulin complex adopts”, “uses”: [“T-Cell Differentiation”, “NK Cell Enhancement”, “Cytokine Modulation”, “NF-κB Inhibition”, “Thymic Support”], “research amount”: “2-6 mg daily”, “route”: “Injectable”, “cycle”: “2-6 or 8-12 weeks”, “storage”: “2-8°C”, “level”: “well”, “category”: “Immune Support, Anti-Inflammatory, Anti-Aging”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “TIR”, “name”: “dual agonist research compounds”, “sub”: “Dual GIP/GLP-1 Receptor Agonist | Hormone Balance & Diabetes”, “desc”: “dual agonist research compounds is a revolutionary dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. FDA-approved for both type 2 diabetes management and chronic weight management, it has demonstrated unprecedented efficacy for hormone balance and metabolic health optimization. dual agonist research compounds works by mimicking incretin hormones that regulate blood sugar, slow gastric”, “uses”: [“Severe Obesity Management”, “Metabolic Syndrome Reversal”, “Body Composition Optimization”, “Type 2 Diabetes Management”, “Insulin Resistance Improvement”], “research amount”: “2.5-15mg weekly”, “route”: “Injectable”, “cycle”: “12-24+ weeks”, “storage”: “2-8°C”, “level”: “extensive”, “category”: “Hormone Balance, Diabetes, Cardiovascular”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Triptorelin”, “name”: “Triptorelin”, “sub”: “Triptorelin (GnRH Super-Agonist)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “100–100 mcg”, “route”: “SubQ”, “cycle”: “Single research amount”, “storage”: “”, “level”: “emerging”, “category”: “Hormonal”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “TRT”, “name”: “TRT”, “sub”: “Testosterone Replacement Therapy | Testosterone Cypionate & Enanthate”, “desc”: “Testosterone Replacement Therapy (TRT) is FDA-approved for treating male hypogonadism (low testosterone) caused by testicular failure or hypothalamic-pituitary dysfunction. Testosterone cypionate and enanthate are the most commonly prescribed injectable esters, providing sustained testosterone levels with weekly or bi-weekly research protocol. The TRAVERSE trial (5,200+ participants) confirmed cardiovascular safety in high-risk men”, “uses”: [“Hypogonadism Treatment”, “Symptom Resolution”, “Quality of Life”, “Increased Lean Mass”, “Reduced Fat Mass”], “research amount”: “75-200mg weekly”, “route”: “Injectable”, “cycle”: “Ongoing (lifetime therapy)”, “storage”: “20-25°C (room temp)”, “level”: “extensive”, “category”: “Hormone Restoration, Body Composition, Metabolic Health”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “VIP”, “name”: “VIP”, “sub”: “VIP (Injectable Form)”, “desc”: “”, “research amount”: “50-100 mcg daily”, “route”: “SubQ”, “cycle”: “4-8 weeks”, “storage”: “Refrigerated (2-8°C)”, “level”: “Well Researched”, “category”: “”, “source”: “luvi”, “url”: “”}, {“abbr”: “Vitamin B12”, “name”: “Vitamin B12”, “sub”: “Methylcobalamin (Vitamin B12)”, “desc”: “”, “uses”: [“Research purposes”], “research amount”: “1000–5000 mcg”, “route”: “IM”, “cycle”: “Ongoing”, “storage”: “”, “level”: “emerging”, “category”: “Performance”, “source”: “peptide.locker”, “url”: “”}, {“abbr”: “WSO”, “name”: “Wolverine Stack”, “sub”: “BPC-157 + TB-500 | Tissue Repair & Recovery Protocol”, “desc”: “The Wolverine Stack combines BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment) for enhanced tissue repair and recovery. Named after the Marvel character known for regenerative abilities, this combination targets complementary healing pathways: BPC-157 increases actin production and promotes angiogenesis via nitric oxide modulation, while TB-500 binds actin to”, “uses”: [“Tendon & Ligament Healing”, “Muscle Injury Recovery”, “Joint Pain & Cartilage”, “Accelerated Wound Closure”, “Reduced Scarring”], “research amount”: “BPC-157: 250-500mcg + TB-500: 2-2.5mg”, “route”: “Injectable”, “cycle”: “4-8 weeks”, “storage”: “2-8°C (reconstituted)”, “level”: “well”, “category”: “Tissue Repair, Wound Healing, Anti-Inflammatory”, “source”: “pep-pedia”, “url”: “”}, {“abbr”: “Zinc-Thymulin”, “name”: “Zinc-Thymulin”, “sub”: “Zinc-Dependent Thymic Nonapeptide | Immune Modulation & Anti-Inflammatory”, “desc”: “Thymulin (also known as Serum Thymic Factor or FTS – Facteur Thymique Sérique) is a 9-amino acid metallopeptide hormone produced exclusively by thymic epithelial cells. First characterized by Bach and colleagues in 1977, thymulin is unique in requiring zinc binding (1:1 equimolecular ratio) for biological activity. The zinc-thymulin complex adopts a specific three-dimensional conformation essential for its immunomodulatory functions, including T-cell differentiation, NK cell enhancement, and suppressor T-cell regulation. Beyond immune functions, thymulin demonstrates potent anti-inflammatory and analgesic properties through inhibition of NF-κB, p38 MAPK, and pro-inflammatory cytokines. Serum thymulin levels decline progressively with age (peaking in pre-adolescence), contributing to immunosenescence. Research shows promise in lung diseases, neuropathic pain, and age-related immune dysfunction, though human clinical trials remain limited.”, “uses”: [“Immunity”, “T-Cell Differentiation”, “Suppressor T-Cell Enhancement”, “NK Cell Activation”, “Inflammation”, “Anti Aging”, “Neuroprotection”], “research amount”: “1-5 mg”, “route”: “Injectable”, “cycle”: “5-10 days”, “storage”: “-20°C (lyophilized)”, “level”: “emerging”, “category”: “Hair Growth”, “source”: “peptide.locker”, “url”: “”}]

Peptide Library Canada: Research Reference Guide

Peptide Library for Canadian Researchers

Peptide Research Reference

Research Uses

Overview